Am­gen re­ports dual Phase 3 wins in atopic der­mati­tis and myas­the­nia gravis

Am­gen re­leased da­ta from two piv­otal tri­als on Tues­day that showed its ex­per­i­men­tal drug ro­catin­limab suc­ceed­ed in a Phase 3 test in atopic der­mati­tis, while …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER